According to WHO, combining casirivimab and imdevimab may reduce the risk of hospitalization and duration of symptoms in unvaccinated, older, or immunosuppressed patients.
Antibody tests indicate past exposure or immune response to vaccine. They, however, cannot detect neutralising antibodies which protect against future infections.
Several institutes and experts advocate see this as an efficacy trial that could help boost confidence in vaccines, especially Bharat Biotech’s Covaxin that is in phase-3 trials.
Until now, most tests could tell only whether antibodies are present. The newer ones measure the quantity of proteins raised by the immune system to disable viral invaders.
The Union department of food and public distribution has asked states to weed out ineligible beneficiaries of PMGKAY by the end of next month. But going by the obvious political risks, the exercise is unlikely to be completed soon.
New bill aims to fix key issues with IBC 2016, including delays & patchy implementation, and protect creditors, with window for genuine promoters to retain control of their companies.
Contrary to claims regarding implementation of theaterisation, ThePrint first reported on 17 June 2021 that it will be delayed. Now, ACM Singh bats for different structure.
Putin sees this as a victory. Europeans have decided to deal with Trump on his terms for the sake of the larger Western alliance. We look at the lessons for us in India.
COMMENTS